Addison Biological
Laboratory, Inc. "Improving the Lives of
Animals Through Innovative and Exclusive
Veterinary Technologies"
MAXI/GUARD® Nasal Vac
MAXI/GUARD®
Nasal
Vac - An avirulent live culture Bordetella bronchiseptica vaccine for the prevention of respiratory disease in baby pigs.
MAXI/GUARD® Nasal Vac features include one dose intranasal
administration, providing benefits of lower labor intensity, less stress (no needles) and lower costs. Nasal Vac is
recognized by both private and corporate swine production facilities as a
valuable disease preventative. Dosage - 1/2 ml into each nostril of
piglets at one to three days of age. Packaged in 30 dose bottles (nasal tips
included).
Click
ad below for
Technical Bulletin
(requires Adobe Acrobat Reader to open)
How Does
it Work?- MAXI/GUARD® Nasal Vac attaches to the ciliated turbinate
epithelium and helps stimulate a secretory IgA response. Nasal
Vac occupies Bordetella bronchiseptica (Bb) receptor sites thus
effectively blocking attachment of pathogenic Bb. By
preventing attachment of pathogenic Bb we help preserve the
integrity of the ciliated epithelium. The ciliated respiratory
epithelium is the primary filter for the upper respiratory
tract. Properly filtered air greatly decreases the pig's
pulmonary challenge from particulate matter and air-born pathogens,
such as Pasteurella multocida and Streptococcus suis.
The vaccinal strain acts by colonizing vulnerable turbinate
surfaces. This organism attaches to cilia near the lumen of
the respiratory tree, rather than invading deeper tissues. Attachment
is dependent upon protein adhesions produced by the organism.
Successful colonization of the piglets ciliated epithelium suggests that there is no maternal interference even if the sow
has IgG antibodies to Bordetella, as these antibodies are not
secreted into the lumen of the piglets respiratory tract. After 21 days, presence of the
competing vaccinal strain is less critical, perhaps due to IgA
development.
Usage -
MAXI/GUARD® Nasal Vac is
administered intranasally (0.5ml/nostril) during the first 1-3 days
of life where it quickly colonizes the nasal turbinate and
respiratory (tracheal, bronchial) ciliated epithelium.
Colonization by this organism is important during the
first 21 days of life as this is a critical period for damage to the
mucociliary apparatus by pathogenic Bordetella. Natural
infection by Pasteurella multocida resulting in severe Atrophic
Rhinitis increases between 12-16 weeks in unprotected animals.
Nasal syringe tips are provided with the vaccine. These enable direct application into the nasal
cavity. The vaccine is delivered as a liquid stream directly
into the nostrils while the piglet is held upright with the head
and nose projected upward.